Ono Pharmaceutical Co., Ltd. (FRA:ON4)
Germany
· Delayed Price · Currency is EUR 11.40
-0.30 (-2.56%)
At close: Dec 5, 2025
Ono Pharmaceutical Ratios and Metrics
Market cap in millions EUR. Fiscal year is April - March.
Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Market Capitalization | 5,466 | 4,651 | 7,065 | 9,345 | 11,215 | 11,112 | Upgrade
|
| Market Cap Growth | 1.75% | -34.18% | -24.40% | -16.67% | 0.92% | 5.90% | Upgrade
|
| Enterprise Value | 5,211 | 4,583 | 6,528 | 8,696 | 10,861 | 10,529 | Upgrade
|
| Last Close Price | 11.40 | 9.52 | 13.82 | 16.74 | 19.44 | - | Upgrade
|
| PE Ratio | 19.57 | 15.04 | 9.01 | 11.97 | 18.79 | 19.13 | Upgrade
|
| PS Ratio | 1.88 | 1.55 | 2.29 | 3.02 | 4.19 | 4.66 | Upgrade
|
| PB Ratio | 1.17 | 0.96 | 1.44 | 1.81 | 2.29 | 2.25 | Upgrade
|
| P/TBV Ratio | 2.24 | 1.75 | 1.57 | 2.01 | 2.56 | 2.55 | Upgrade
|
| P/FCF Ratio | 9.91 | 9.77 | 10.81 | 8.75 | 26.86 | 21.54 | Upgrade
|
| P/OCF Ratio | 9.28 | 9.13 | 10.42 | 8.46 | 24.47 | 19.50 | Upgrade
|
| EV/Sales Ratio | 1.87 | 1.52 | 2.12 | 2.81 | 4.05 | 4.42 | Upgrade
|
| EV/EBITDA Ratio | 9.96 | 8.36 | 5.97 | 7.50 | 11.40 | 11.93 | Upgrade
|
| EV/EBIT Ratio | 16.22 | 12.00 | 6.65 | 8.37 | 13.22 | 13.84 | Upgrade
|
| EV/FCF Ratio | 9.45 | 9.63 | 9.99 | 8.14 | 26.01 | 20.41 | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.19 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.38 | 1.65 | 0.05 | 0.05 | 0.07 | 0.08 | Upgrade
|
| Debt / FCF Ratio | 1.36 | 1.90 | 0.08 | 0.06 | 0.16 | 0.14 | Upgrade
|
| Asset Turnover | 0.48 | 0.49 | 0.56 | 0.55 | 0.49 | 0.44 | Upgrade
|
| Inventory Turnover | 2.69 | 2.40 | 2.72 | 2.54 | 2.31 | 2.38 | Upgrade
|
| Quick Ratio | 2.29 | 2.32 | 2.92 | 1.71 | 2.56 | 1.58 | Upgrade
|
| Current Ratio | 2.99 | 3.07 | 3.99 | 2.81 | 4.27 | 2.64 | Upgrade
|
| Return on Equity (ROE) | 6.06% | 6.32% | 16.56% | 16.02% | 12.39% | 12.49% | Upgrade
|
| Return on Assets (ROA) | 3.44% | 3.91% | 11.16% | 11.57% | 9.32% | 8.69% | Upgrade
|
| Return on Capital (ROIC) | 3.83% | 4.43% | 12.81% | 13.14% | 10.49% | 10.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 6.70% | 19.80% | 19.80% | 16.50% | 15.10% | Upgrade
|
| Earnings Yield | 5.11% | 6.65% | 11.10% | 8.35% | 5.32% | 5.23% | Upgrade
|
| FCF Yield | 10.09% | 10.23% | 9.25% | 11.43% | 3.72% | 4.64% | Upgrade
|
| Dividend Yield | 4.13% | 5.19% | 3.55% | 2.90% | 2.14% | - | Upgrade
|
| Payout Ratio | 77.38% | 74.96% | 29.05% | 26.38% | 34.36% | 29.76% | Upgrade
|
| Buyback Yield / Dilution | 0.45% | 2.14% | 1.70% | 1.65% | 0.54% | 0.96% | Upgrade
|
| Total Shareholder Return | 4.57% | 7.33% | 5.25% | 4.54% | 2.67% | 0.96% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.